74 reports

  • forced expiratory volume in 1 second (FEV1) or on reducing exacerbations requiring emergency room visits and/or hospitalization.

About ## percent of people who have food allergies are allergic to more than one food.

  • Health Services
  • Therapy
  • Canada
  • United States
  • Product Initiative
  • Oct 10, 2017: Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis

Food and Drug Administration (FDA) in 1977 for allergies, the drug has been available over the counter in generic form since 1993.

  • Health Services
  • Pharmaceutical
  • Therapy
  • United States
  • Aduro BioTech, Inc.

The drug candidates target the allergens (Derp ##) that can trigger allergies and asthma attacks directly.

  • Asthma
  • Health Services
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC

Anti-Allergy Drugs ##. ##. ##. ##.

  • Health Services
  • Ophthalmology
  • Therapy
  • World
  • Forecast

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Ear Disease
  • Health Services
  • World
  • Product Initiative
  • Sensorion S.A.
  • GEOGRAPHICAL SEGMENTATION
  • GLOBAL ALLERGY DIAGNOSTICS MARKET BY GEOGRAPHY 2017-2022 (%)

Environmental pollutants and few chemical substances present in food and drugs may cause different types of food, skin, and drug sensitive allergies and asthma.

  • Health Services
  • Hospital
  • Danaher Corporation
  • Hitachi, Ltd.
  • Thermo Fisher Scientific, Inc.

To support the partnership, the Abbott Fund is providing US$## million funds over three years.

  • Biotech Diagnostics
  • Health Services
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.

The drug candidate acts by blocking the histamine receptors and prevents the excess mucus production associated with ocular allergy.

  • Ear Disease
  • Health Services
  • Molecular Diagnostics
  • Therapy
  • Sensorion S.A.

Hoffmann-La Roche Ltd ## ## ## ## ## AnaptysBio Inc ## ## ## ## ## Food Allergy Research & Education Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Droege International Group AG ## ## ## ## ## Allertein Therapeutics LLC ## ## ## ## ## Allergy Therapeutics

  • Allergy
  • Clinical Trial
  • Health Services
  • Medical Biotechnology
  • Aimmune Therapeutics, Inc.

The drug candidate is in Phase II stage for peanut allergy, grass pollen allergy, chronic urticaria, and dermatitis globally.

  • Chronic Disease
  • Health Services
  • Monoclonal Antibody
  • Respiratory Disease
  • Regeneron Pharmaceuticals, Inc.

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cell Therapy
  • Health Services
  • Therapy
  • Bristol-Myers Squibb Company
  • 6.1 OVERVIEW

WORLD ALLERGY ORGANIZATION JOURNAL, ##(##), PP. ##-##.

  • Allergy
  • Health Services
  • United States
  • World
  • Aimmune Therapeutics, Inc.

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Diagnostics
  • Health Services
  • In Vitro Diagnostics
  • Medical Device
  • Point Of Care Testing

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Diagnostics
  • Health Services
  • In Vitro Diagnostics
  • Medical Device
  • Point Of Care Testing

According to research carried out by the Allergy, Genes and Environment Network (AllerGen), as of 2015, ## in ## Canadians or ##. ## million Canadians are affected by food allergies.

  • Diabetes
  • Health Services
  • Injectable Delivery
  • United States
  • Amgen Inc.
  • 2.1 RELATED REPORTS

Peanut Allergy: Global Drug Forecast and Market Analysis to 2027, GDHC##PIDR GlobalData (2016).

  • Epidemiology
  • Health Services
  • United States
  • World
  • Forecast

About ## percent of people who have food allergies are allergic to more than one food.

  • Health Services
  • Therapy
  • Canada
  • United States
  • Product Initiative

DRUG HYPERSENSITIVITY REACTIONS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2019* PROMINENT DRUGS DRUG HYPERSENSITIVITY REACTIONS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2019*

  • Clinical Trial
  • Health Services
  • Therapy
  • World
  • Product Initiative
  • Developments

Egg allergy is one of the most common food allergies.

  • Health Services
  • North America
  • United States
  • World
  • Market Size
  • Clinical Trial profile. 330 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Development
  • Health Services
  • Pharmaceutical
  • World

This functionality of behavioral health software is mainly used for evaluating patient drug allergies, drug-drug interactions, drug dosing, therapy critiquing and planning, prescribing, information retrieval, image recognition & interpretations, and c

  • Health Services
  • North America
  • United States
  • World
  • Market Size
  • Clinical Trial profile. 80 Trial Title
  • 5. All the trials included are unique trials.

ALLERGIC CONJUNCTIVITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ALLERGIC CONJUNCTIVITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ALLERGIC CONJUNCTIVITIS THERAPEUT

  • Health Services
  • OTC
  • Pharmaceutical
  • World
  • Product Initiative

Note: Deals include all announced pharmaceuticals & healthcare deals from 2012 onwards, GlobalData UCB SA, Medical Devices Deals, 2012 to YTD 2018 Device Type Neurology Devices Dental Devices Drug Delivery Devices HealthCare IT In Vitro Diagnostics Medical Equipment Distributors Nephrol

  • Health Services
  • Neurological Disorder
  • Pharmaceutical
  • United States
  • UCB S.A.

About ## percent of people who have food allergies are allergic to more than one food.

  • Chronic Disease
  • Health Services
  • Monoclonal Antibody
  • Respiratory Disease
  • Regeneron Pharmaceuticals, Inc.

Food and Drug Administration (FDA).

  • Health Services
  • North America
  • United States
  • bioMerieux S.A.
  • Danaher Corporation
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Eye Disease
  • Health Services
  • OTC
  • World
  • Product Initiative

WRINKLES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS WRINKLES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* WRINKLES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL

  • Clinical Trial
  • Drug Development
  • Health Services
  • World
  • Product Initiative

About ## percent of people who have food allergies are allergic to more than one food.

  • Health Services
  • Medical Biotechnology
  • Monoclonal Antibody
  • Respiratory Disease
  • Regeneron Pharmaceuticals, Inc.
  • SMART CONTACT LENSES - PRODUCT DESCRIPTION

PDR## (PD-## Antagonist) received orphan drug designation from FDA for treatment of neuroendocrine tumors.

  • Health Services
  • Medical Device
  • United States
  • Company
  • Valeant Pharmaceuticals International, Inc.

PROMINENT DRUGS RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* RESPIRATORY FAILURE THERAPEUTICS CLINICAL

  • Health Services
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative